Clinical Trials Directory

Trials / Unknown

UnknownNCT05665010

Precise Stratification of Genetic Risk of Ovarian Function Impairment

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Tongji Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Aging is a common problem in human society at present. The fertility decline, perimenopausal symptoms and senile diseases caused by ovarian aging seriously affect women's own health, offspring's health, family and social stability, and endanger national population security. Accurate stratification of genetic risk of ovarian aging has practical significance. Early and accurate identification of high-risk groups of premature ovarian aging can help such women to start early protection of ovarian function, preserve fertility to a greater extent, improve fertility quality, and also be conducive to early prevention and treatment of other systemic diseases and prognosis.

Conditions

Interventions

TypeNameDescription
OTHERGenetic susceptibilityGenetic susceptibility increases the risk of ovarian injury

Timeline

Start date
2021-11-01
Primary completion
2023-10-31
Completion
2024-10-31
First posted
2022-12-27
Last updated
2022-12-27

Locations

18 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05665010. Inclusion in this directory is not an endorsement.